JPMorgan Chase & Co’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.9K Sell
22,979
-582,065
-96% -$528K ﹤0.01% 5313
2025
Q1
$273K Sell
605,044
-341,355
-36% -$154K ﹤0.01% 4313
2024
Q4
$476K Buy
946,399
+269,237
+40% +$135K ﹤0.01% 4177
2024
Q3
$613K Buy
677,162
+82,864
+14% +$75K ﹤0.01% 3905
2024
Q2
$593K Sell
594,298
-81,406
-12% -$81.2K ﹤0.01% 3774
2024
Q1
$1M Sell
675,704
-51,309
-7% -$75.9K ﹤0.01% 3573
2023
Q4
$792K Buy
727,013
+17,535
+2% +$19.1K ﹤0.01% 3671
2023
Q3
$837K Sell
709,478
-331,009
-32% -$391K ﹤0.01% 3489
2023
Q2
$1.47M Sell
1,040,487
-71,624
-6% -$101K ﹤0.01% 3209
2023
Q1
$1.67M Buy
1,112,111
+23,532
+2% +$35.3K ﹤0.01% 3145
2022
Q4
$1.27M Buy
1,088,579
+39,528
+4% +$46.3K ﹤0.01% 3231
2022
Q3
$1.19M Sell
1,049,051
-207,881
-17% -$235K ﹤0.01% 3242
2022
Q2
$1.99M Sell
1,256,932
-592,730
-32% -$937K ﹤0.01% 3015
2022
Q1
$2.85M Buy
1,849,662
+566,385
+44% +$872K ﹤0.01% 2947
2021
Q4
$3.15M Sell
1,283,277
-932,515
-42% -$2.29M ﹤0.01% 2895
2021
Q3
$5.58M Buy
2,215,792
+263,684
+14% +$665K ﹤0.01% 2508
2021
Q2
$5.56M Buy
1,952,108
+1,952,035
+2,674,021% +$5.56M ﹤0.01% 2571
2021
Q1
$0 Sell
73
-2,189
-97% ﹤0.01% 5312
2020
Q4
$4K Sell
2,262
-10,282
-82% -$18.2K ﹤0.01% 4742
2020
Q3
$12K Buy
12,544
+7,008
+127% +$6.7K ﹤0.01% 4573
2020
Q2
$5K Sell
5,536
-173,310
-97% -$157K ﹤0.01% 4560
2020
Q1
$148K Buy
178,846
+37,000
+26% +$30.6K ﹤0.01% 3815
2019
Q4
$127K Buy
141,846
+106,390
+300% +$95.3K ﹤0.01% 3950
2019
Q3
$35K Buy
35,456
+5,751
+19% +$5.68K ﹤0.01% 4358
2019
Q2
$31K Buy
29,705
+2,170
+8% +$2.27K ﹤0.01% 4426
2019
Q1
$36K Sell
27,535
-13,466
-33% -$17.6K ﹤0.01% 4343
2018
Q4
$38K Buy
41,001
+17,294
+73% +$16K ﹤0.01% 4353
2018
Q3
$49K Buy
23,707
+2,922
+14% +$6.04K ﹤0.01% 4360
2018
Q2
$37K Buy
20,785
+855
+4% +$1.52K ﹤0.01% 4404
2018
Q1
$47K Sell
19,930
-61,916
-76% -$146K ﹤0.01% 4171
2017
Q4
$154K Buy
+81,846
New +$154K ﹤0.01% 3758
2016
Q3
Sell
-2,270
Closed -$5K 4172
2016
Q2
$5K Hold
2,270
﹤0.01% 3937
2016
Q1
$6K Sell
2,270
-1,219
-35% -$3.22K ﹤0.01% 3841
2015
Q4
$12K Buy
+3,489
New +$12K ﹤0.01% 3587
2013
Q4
Sell
-13,495
Closed -$41K 3695
2013
Q3
$41K Buy
+13,495
New +$41K ﹤0.01% 3834